CONTEXT AND OBJECTIVE: The Wnt pathway is involved in tumorigenesis of several tissues. RESULTS: Regarding Wnt1, FZD1 and Wnt5a expression, no significant association was observed between the groups. A significant association was observed between the groups in relation to FZD5 expression (P = 0.001). The proportion of FZD5-positive samples was significantly higher in group A (80.0%) than in group B (31.1%). Regarding the survival curve for FZD5 in group B, we did not find any significant association between atrophic endometrium and endometrial adenocarcinoma. We also did not find any significant association regarding beta-catenin expression (P = 1.000 Comparamos a expressão imunoistoquímica de Wnt 1, Frizzled-1 (FZD1), Wnt 5a, Frizzled-5 (FZD 5) e betacatenina entre câncer endometrial tipo I e endométrio atrófico. RESULTADOS: Na expressão do Wnt1, FZD1 e Wnt5a, não observamos associação significante entre os grupos. Na expressão do FZD5, encontramos associação significante entre os grupos (P = 0,001). A proporção de positividade do FZD5 foi significantemente maior no grupo A comparado ao grupo B (31,1%). Em relação à curva de sobrevida para o FZD5 no grupo B, não tivemos associação significante entre endométrio atrófico e adenocarcinoma do endométrio. Também não observamos associação significante na expressão da beta-catenina (P = 1,000). CONCLUSÃO: FZD5 é downregulated no adenocarcinoma endometrial quando comparado ao endométrio atrófico.
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Canonical and noncanonical Wnt pathways: a comparison between endometrial cancer type I and atrophic endometrium in Brazil
Vias Wnt canônica e não canônica: uma comparação entre o câncer endometrial tipo I e endométrio atrófico no Brasil The material was divided into two groups according to tissue type: Group A, atrophic endometrium (n = 15); and Group B, endometrial adenocarcinoma (n = 45). We compared the immunohistochemical expression of Wnt1, Frizzled-1 (FZD1), Wnt5a, Frizzled-5 (FZD5) and beta-catenin between endometrial cancer type I and atrophic endometrium. RESULTS: Regarding Wnt1, FZD1 and Wnt5a expression, no significant association was observed between the groups. A significant association was observed between the groups in relation to FZD5 expression (P = 0.001). The proportion of FZD5-positive samples was significantly higher in group A (80.0%) than in group B (31.1%). Regarding the survival curve for FZD5 in group B, we did not find any significant association between atrophic endometrium and endometrial adenocarcinoma. We also did not find any significant association regarding beta-catenin expression (P = 1.000 
INTRODUCTION
The Wnt family has an important role in tumorigenesis and embryogenesis. [1] [2] [3] [4] [5] Wnts are an evolutionarily highly conserved family of genes/proteins that act through three signaling pathways. 6 The canonical pathway involves regulation of betacatenin. Briefly, in the absence of Wnt signaling, a multiprotein complex that includes adenomatous polyposis coli (APC), The clinical and surgical staging and histological typing were performed in accordance with the classification of the International Federation of Gynecology and Obstetrics. 9 The study was approved by the Institutional Ethics Committee (Unifesp).
RESULTS
Most of the patients in group B were staged as IB and IC ( Table 1) .
In all cases, expression of the markers was found practically only in the cytoplasm (Figure 1 ).
Regarding Wnt1, FZD1 and Wnt5a expression, no significant difference was observed between the groups. No significant difference in beta-catenin expression was observed between patient groups, since the expressions for groups A and B were 100% and 95.6%, respectively (P = 1.000).
DISCUSSION
Canonical pathway
Endometrioid endometrial adenocarcinoma is essentially connected with type I endometrial cancer, which in turn correlates with hyperestrogenism status. Hence, the key to understanding the role of Wnt signaling in type I endometrial cancer is to find the link between Wnts and estrogen signaling. Many authors have suggested that a mutation of beta-catenin/CTNNB1 in the endometrium would lead to nuclear accumulation of beta-catenin and then result in uterine endometrioid cancer. [1] [2] [3] Pijnenborg et al. 3 found nuclear accumulation of beta-catenin in 38% of their endometrioid endometrial cancer cases, while Kariola et al. found 53% and Schlosshauer et al. found 47%. 4, 5 On the other hand, we found no difference in beta-catenin expression between cases of atrophic endometrium and endometrial cancer, since both groups stained almost equally in the cytoplasm. This may be explained by the fact that beta-catenin has a low level of association with endometrial cancer, compared with loss of PTEN (phosphatase and tensin homologue protein). 6 Furthermore, it seems that PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas. 7 It is possible that beta-catenin has a more important role in relation to precursor lesions than in uterine cancer itself.
Hideyuki et al. found nuclear beta-catenin in 70% of their endometrial hyperplasia samples and 56.7% of their endometrial cancer samples. However, they also showed that nuclear staining of beta-catenin occurred in the mid-proliferative, late proliferative and early secretion phases of the normal endometrium during the menstrual cycle. Twelve out of 15 cases (80.0%) during these periods showed nuclear staining. 8 All these findings are concordant with reports that correlate estrogens with the canonical Wnt pathway, thus suggesting that estrogens or estrogen receptors are capable of stimulating betacatenin accumulation. 10, 11 Comparing lean and obese rats, Zhang et al. found that estrogen more strongly induced the antiproliferative genes retinaldehyde dehydrogenase-2 and secreted frizzled-related protein-4 (a negative regulator of Wnt signaling) in lean rats, but had little or no effect on obese rats.
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Noncanonical pathway
Both groups reached total staining for Wnt5a, and the proportion of FZD5-positive women was significantly higher in group A (80.0%) than in group B (31.1%).
It is known that noncanonical signaling can inhibit canonical signaling through a variety of mechanisms. 13 We suggest that because of the low proportion of FZD5 positivity in the adenocarcinoma group, the noncanonical signaling could not function properly and that this subsequently led to development of hyperplasia and cancer. cancer. 19 However, endometrioid ovarian cancer is an exception to this. This neoplasia has a molecular pattern similar to that of endometrial adenocarcinoma, with regard to the Wnt pathway.
In fact, in this respect, we suggest that low activity of the nonca- Regarding the survival curve for FZD5, there was a tendency towards better prognosis for FZD5-positive women, but this association was not significant. This also strengthens the idea that the noncanonical Wnt pathway has a protective function in relation to endometrial carcinoma. The more we learn about the Wnt family and its interactions, the more we obtain new insights into old problems.
CONCLUSION
Wnts can produce different effects depending on the context.
Here, we showed that FZD5 is downregulated in type I endometrial adenocarcinoma, compared with atrophic endometrium. 
